Are you Annu Khajuria?

Claim your profile

Publications (3)4.9 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are several reports from locations in the northern hemisphere of seasonal variation in hemoglobin A1c (HbA1c) levels with higher values noted in the cooler months. The variation has been attributed to holiday seasons, temperature differences, and changes in diet. This article describes the seasonal variation in both hemispheres and in a country on the equator with minimal temperature variation. The mean and median HbA1c by month was calculated for a maximum of 2 years for HbA1c data from the different locations: Edmonton and Calgary, Canada; Singapore; Melbourne, Australia; and Marshfield, Wisconsin. The mean monthly temperature for each location was found from available meteorological information. In both northern and southern hemispheres, the HbA1c was higher in cooler months and lower in the warmer months. In Singapore, where there is minimal temperature variation, there is also minimal variation in HbA1c values over the year. The difference in HbA1c over a year appears to be related to the difference in temperature. Hemoglobin A1c is higher in cooler months and lower in the warmer months in both hemispheres. In a country with minimal monthly temperature variation, there is only minimal variation in HbA1c values through the year. In all locations, the mean and median HbA1c declined over the study period, possibly due to better glycemic control of patients with diabetes or an increase in use of HbA1c as a screening test for diabetes or a combination of both.
    Journal of diabetes science and technology 07/2009; 3(4):668-71.
  • Trefor N Higgins, Annu Khajuria, Melissa Mack
    [Show abstract] [Hide abstract]
    ABSTRACT: We studied whether problems quantifying hemoglobin A(2) (HbA(2)) could be resolved by using capillary electrophoresis. HbA(2) was quantified on whole blood samples from patients with and without beta-thalassemia trait and patients heterozygous for HbE, HbS, HbC, and HbD Punjab using the VARIANT II beta-thalassemia (Bio-Rad, Hercules, CA) and Capillarys 2 (Sebia, Norcross, GA). HbA(2) results in patients with and without beta-thalassemia trait were lower with the Capillarys 2 system. Reasonable HbA(2) results were obtained for patients with HbD Punjab and HbE traits on the Capillarys 2. HbA(2) results for patients with HbS, heterozygous and homozygous, were similar by both methods. Interference due to coelution for HbA(2) results for patients with HbC trait was noted on the Capillarys 2. Between-day imprecision on the VARIANT II is less than that for the Capillarys 2 system. The Capillarys 2 is superior to the VARIANT II for quantifying HbA(2) in the presence of HbE and HbD Punjab traits. The Capillarys 2 offers only slight advantages over the VARIANT II for quantifying HbA(2) in the presence of heterozygous and homozygous HbS. The Capillarys 2 gives inferior HbA(2) results for patients with HbC trait.
    American Journal of Clinical Pathology 04/2009; 131(3):357-62. · 2.88 Impact Factor
  • Trefor Higgins, Melissa Mack, Annu Khajuria
    [Show abstract] [Hide abstract]
    ABSTRACT: The Sebia Capillarys 2, a capillary electrophoresis method, was compared to a high performance liquid chromatography (HPLC) and electrophoresis at alkaline and acid pH for the presumptive identification and quantitation of hemoglobin variants. The concordance of hemoglobin variant identification on the Sebia Capillarys 2 with the combination of HPLC and electrophoresis at alkaline and acid pH was evaluated by analyzing samples on both systems. The quantification, expressed as % of total hemoglobin, of the common hemoglobin variants on the Capillarys 2 and the Bio Rad VARIANT II beta thalassemia methods were compared. The % hemoglobin variant results for the two methods were similar for HbS and slightly different for HbC and D Punjab and significantly different for HbE. The Sebia Capillarys 2 correctly identified a number of hemoglobin variants. The Sebia Capillarys 2 is suitable for the presumptive identification and quantification of hemoglobin variants producing results comparable with existing HPLC and electrophoresis methods.
    Clinical biochemistry 02/2009; 42(7-8):701-5. · 2.02 Impact Factor